Current Drug Discovery Technologies
Volume 16, 4 Issues, 2019
ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)
This journal supports open access
ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)
This journal supports open access
Contents
Current Drug Discovery Technologies, Volume 4 - Number 1
Activity-Based Proteomics of Lipolytic Enzymes
, 4(1): 1 - 11Ruth Birner-Gruenberger and Albin Hermetter
DOI: 10.2174/157016307781115458
Microarray Analysis Reveals CCL24/Eotaxin-2 as an Effector of the Pathogenetic Effects Induced by HIV-1 Nef
, 4(1): 12 - 23Gianna Fiorucci, Eleonora Olivetta, Maria Vincenza Chiantore and Maurizio Federico
DOI: 10.2174/157016307781115502
Controlled Release of the Pineal Hormone Melatonin from Hydroxypropylmethylcellulose/Sodium Alginate Matrices in Aqueous Media Containing Dioctyl Sulfosuccinate
, 4(1): 31 - 38Marilena Vlachou, Athanasia Tsiakoulia and Aphrodite Eikosipentaki
DOI: 10.2174/157016307781115449
Targetability of Human Disease Genes
, 4(1): 48 - 58Meena K. Sakharkar and Kishore R. Sakharkar
DOI: 10.2174/157016307781115494
Pharmacogenomics of Sex Difference in Chemotherapeutic Toxicity
, 4(1): 59 - 68Jeffrey Wang and Ying Huang
DOI: 10.2174/157016307781115485
  |
Editor-in-Chief
Vladimir P. Torchilin
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Discovery Technologies Journal was launched in 2004. Dr. Vladimir P. Torchilin serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.81
New eBook
 |
Frontiers in Clinical Drug Research – Alzheimer DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net